Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Hematol. 2013 Nov 20;89(1):68–73. doi: 10.1002/ajh.23590

Figure 5. Plasma levels of TF and FVIIa/AT complex.

Figure 5

Plasma levels of TF antigen and FVIIa/AT complex, an indirect marker of in vivo TF exposure and inhibition, were measured by ELISA in ET patients and controls. For ET patients data are shown as overall group and according to JAK2V617F mutational status. *=p<0.05 vs controls.